If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInduction Heal. Regulatory News (INHC)

  • This share is currently suspended. It was suspended at a price of 9.75
  • There is currently no data for INHC

Named Supplier on NHSX Procurement Framework

28 Aug 2020 07:00

RNS Number : 3839X
Induction Healthcare Group PLC
28 August 2020
 

 

28 August 2020

 

Induction Healthcare Group PLC

 

("Induction", the "Company", or the "Group")

 

Induction Switch named Supplier on NHSX Clinical Communications Procurement Framework

 

Induction Healthcare, a leading healthcare technology company that helps healthcare professionals deliver better care more efficiently, today announces that its Induction Switch platform has been awarded the status of Supplier on the Clinical Communications Procurement Framework run by the National Commercial and Procurement Hub on behalf of NHSX, a joint unit dedicated to driving forward the digital transformation of care in the UK.

 

The Procurement Framework has been established to support NHS organisations by providing clinicians with access to a wide range of dedicated clinical facing communication and task management tools to accelerate the adoption of proven technologies. The Framework has been granted £3 million of government funding to aid the move towards more modern forms of communication and to phase out pagers by the end of 2021.1 The Framework is scheduled to run from 3 August 2020 to 3 August 2022, with a possible extension of a further 12 months.2

 

Induction Healthcare products are routinely used by hundreds of thousands of NHS staff and patients, and have been heavily relied upon during the COVID-19 pandemic to deliver care under challenging conditions. The inclusion of Induction Switch on this framework provides strong validation of the Company's high standards of Clinical Safety, Data Security and Information Governance, further supported by the Company's ISO 27001, ISO 9001, Cyber Essentials, and NHS DSPT certifications.

 

Hugo Stephenson, joint CEO of Induction, commented: "We are proud to have been selected for the NHSX Clinical Communications Procurement Framework and are confident it will enable easier access to clinical facing communication and task management tools used by hundreds of thousands of NHS staff across the UK on a daily basis. This success highlights, once again, the strength of Induction's technology and its commitment to improve the delivery of care."

 

As the procurement framework has now been officially launched, the Company expects procurement activity across the NHS to begin in the near future.

 

ENQUIRIES: 

 

 

Induction Healthcare

Via FTI Consulting

Dr Hugo Stephenson, Joint Chief Executive Officer

 

James Balmain, Joint Chief Executive Officer

 

 

 

  

Numis Securities (Nominated Adviser and Broker)

+44 (0) 207 260 1000

James Black / Freddie Barnfield / Huw Jeremy / Matthew Jones

 

 

 

  

FTI Consulting

+44 (0) 203 727 1000

Jamie Ricketts / Elena Kalinskaya / Sam Purewal / Mary Whittow

 

 

 

About Induction 

 

Induction Healthcare Group PLC is a leading healthcare technology company that helps healthcare professionals deliver better care more efficiently. The Group has three platforms, Induction, MicroGuide, and Zesty that support healthcare professionals in multiple markets, including the UK, Ireland, Australia & South Africa, plus Zesty, a leading provider of patient portals to NHS Hospitals in the UK. 

 

Induction is the number one healthcare collaboration app in the UK, used by the majority of hospital doctors within the NHS. The app helps over 140,000 registered users in multiple territories to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting. 

 

The MicroGuide platform provides medical organisations with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. The platform helps over 170,000 registered users in multiple territories, including the majority of hospital trusts within the NHS. 

 

The Zesty platform enables patients to manage their care direct from their smartphone. The Zesty patient portal removes the friction from everyday health related tasks, like booking and managing appointments, reading letters digitally and sharing copies of electronic medical records. 

 

 

1 https://www.contractsfinder.service.gov.uk/Notice/100f0132-1c2b-40aa-a79f-f3c91545c448 

2 https://www.nhsx.nhs.uk/key-tools-and-info/clinical-communications-procurement-framework/ 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
 
END
 
 
NRAFLFERTIIDFII
Date   Source Headline
17th Apr 20253:00 pmRNSForm 8.3 - Induction Healthcare Group plc
17th Apr 20253:00 pmRNSForm 8.3 - Induction Healthcare Group plc
17th Apr 202511:55 amRNSForm 8.3 - Induction Healthcare Group plc
17th Apr 202510:51 amRNSForm 8.5 (EPT/RI)
17th Apr 20257:00 amRNSPublication of Scheme Document
16th Apr 202510:50 amRNSForm 8.5 (EPT/RI)
11th Apr 20252:29 pmEQSForm 8.3 - Induction Healthcare Group PLC - Opening Position Disclosure
11th Apr 202511:46 amRNSForm 8.5 (EPT/RI)
11th Apr 202511:14 amRNSForm 8.3 - Induction Healthcare Group Plc
10th Apr 202512:45 pmRNSRecommended Cash Acquisition
9th Apr 20256:15 pmRNSDirectorate Change
28th Jan 20257:00 amRNSBlock listing Interim Review
2nd Dec 20247:00 amRNSNew Contract in Republic of Ireland
5th Nov 20247:00 amRNSHalf-year Report
30th Oct 20247:00 amRNSMaterial new contract & Notice of Interim Results
13th Aug 20241:29 pmRNSResult of AGM
29th Jul 202410:00 amRNSBlock Listing Six Monthly Return
17th Jul 20247:00 amRNSGrant of Options
4th Jul 20247:00 amRNSFinal Results
1st Jul 202411:07 amRNSAMENDMENT: DIVESTMENT OF HORIZON
1st Jul 20247:00 amRNSDIVESTMENT OF HORIZON STRATEGIC PARTNERS LIMITED
27th Jun 20247:00 amRNSPublication of Full Year Financial Results Delayed
29th Apr 20247:00 amRNSFull Year Trading Update
29th Jan 20247:00 amRNSBlock listing Interim Review
7th Nov 20237:00 amRNSHalf-year Report
10th Oct 20237:00 amRNSUpdate on NHS National Portals Contracts
31st Jul 20233:13 pmRNSBlock listing Interim Review
31st Jul 20237:00 amRNSAudited Final Results
30th Jun 20237:00 amRNSBoard Changes and Trading Update
18th Apr 20237:00 amRNSTrading Update for year ending 31 March 2023
27th Jan 20237:00 amRNSBlock Listing Six Monthly Return
17th Jan 20237:00 amRNSChange of Registered Office
16th Jan 202312:20 pmRNSDirector/PDMR Shareholding
11th Jan 202312:52 pmRNSResults of 2022 Annual General Meeting
9th Jan 20237:00 amRNSDirectorate Changes
20th Dec 20227:00 amRNSChange of Auditor
20th Dec 20227:00 amRNSNotice of AGM
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Dec 202211:05 amRNSSecond Price Monitoring Extn
5th Dec 202211:00 amRNSPrice Monitoring Extension
5th Dec 20227:01 amRNSDirectorate Changes
5th Dec 20227:00 amRNSHalf-year Report
29th Nov 202212:01 pmEQSInduction Healthcare Group focused on 'building out core capability'
28th Nov 20227:01 amRNSNotice of Half-year results
28th Nov 20227:00 amRNSAudited Final Results
24th Oct 20227:00 amRNSUpdate on publication of Audited Final Results
22nd Sep 20227:00 amRNSExtension to 2022 annual reporting deadline

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.